The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.

Authors

Carolin Pfannstiel
Pamela L Strissel
Katherine B Chiappinelli, George Washington University
Danijel Sikic
Sven Wach
Ralph Wirtz
Adrian Wullweber
Helge Taubert
Johannes Breyer
Wolfgang Otto
Thomas Worst
Maximilian Burger
Bernd Wullich
Christian Bolenz
Nicole Fuhrich
Carol I Geppert
Veronika Weyerer
Robert Stöhr
Simone Bertz
Bastian Keck
Franziska Erlmeier
Philipp Erben
Arndt Hartmann
Reiner Strick
Markus Eckstein

Document Type

Journal Article

Publication Date

4-15-2019

Journal

Cancer Immunology Research

DOI

10.1158/2326-6066.CIR-18-0758

Comments

Epub ahead of print

APA Citation

Pfannstiel, C., Strissel, P., Chiappinelli, K., Sikic, D., Wach, S., Wirtz, R., Wullweber, A., Taubert, H., Breyer, J., Otto, W., Worst, T., Burger, M., Wullich, B., Bolenz, C., Fuhrich, N., Geppert, C., Weyerer, V., Stöhr, R., Bertz, S., Keck, B., Erlmeier, F., Erben, P., Hartmann, A., Strick, R., & Eckstein, M. (2019). The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.. Cancer Immunology Research, (). http://dx.doi.org/10.1158/2326-6066.CIR-18-0758

Peer Reviewed

1